Target Validation Information
Target ID T58470
Target Name Cyclin-A2
Target Type
Discontinued
Drug Potency against Target GW-8510 Drug Info IC50 = 10 nM [1]
NU-2058 Drug Info IC50 = 17000 nM [2]
6-(Cyclohex-3-enylmethoxy)-9H-purin-2-ylamine Drug Info IC50 = 13000 nM [3]
MERIOLIN 8 Drug Info IC50 = 1200 nM [4]
4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)-phenol Drug Info IC50 = 120 nM [5]
PD-0183812 Drug Info IC50 = 209 nM [6]
2,5-dichloro-N-p-tolylthiophene-3-sulfonamide Drug Info IC50 = 800 nM
NU-6027 Drug Info IC50 = 2200 nM [7]
MERIOLIN 7 Drug Info IC50 = 5300 nM [4]
4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol Drug Info IC50 = 350 nM [8]
4-(phenyldiazenyl)-1H-pyrazole-3,5-diamine Drug Info IC50 = 15000 nM [8]
PURVALANOLA Drug Info IC50 = 30 nM [9]
RESCOVITINE Drug Info IC50 = 500 nM [10]
MERIOLIN 5 Drug Info IC50 = 5.6 nM [4]
MERIOLIN 4 Drug Info IC50 = 7 nM [4]
MERIOLIN 2 Drug Info IC50 = 18 nM [4]
MERIOLIN 3 Drug Info IC50 = 6 nM [4]
MERIOLIN 1 Drug Info IC50 = 26 nM [4]
3-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol Drug Info IC50 = 1500 nM [8]
MERIOLIN 6 Drug Info IC50 = 5.6 nM [4]
References
REF 1Bioorg Med Chem Lett. 2004 Feb 23;14(4):953-7.Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles.
REF 2J Med Chem. 2004 Jul 15;47(15):3710-22.N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2.
REF 3J Med Chem. 2002 Aug 1;45(16):3381-93.Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives.
REF 4J Med Chem. 2008 Feb 28;51(4):737-51. Epub 2008 Jan 31.Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolincomplex.
REF 5J Med Chem. 2003 Jan 16;46(2):222-36.Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects.
REF 6J Med Chem. 2000 Nov 30;43(24):4606-16.Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases.
REF 7Bioorg Med Chem Lett. 2003 Jan 20;13(2):217-22.4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2.
REF 8J Med Chem. 2006 Nov 2;49(22):6500-9.4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.
REF 9Biochem J. 2007 Dec 15;408(3):297-315.The selectivity of protein kinase inhibitors: a further update.
REF 10Eur J Med Chem. 2010 Mar;45(3):1158-66. Epub 2009 Dec 21.Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.